市場調査レポート
商品コード
1452927
麻酔装置の世界市場、2024-2031年Global Anesthesia Devices Market 2024-2031 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
麻酔装置の世界市場、2024-2031年 |
出版日: 2024年02月01日
発行: Orion Market Research
ページ情報: 英文 195 Pages
納期: 2~3営業日
|
世界の麻酔装置市場は、予測期間中にCAGR 7.5%でかなりの成長が見込まれます。麻酔を必要とする外科手術件数の大幅な増加とともに、麻酔デリバリーおよびモニタリング技術の進歩が続いていることが、世界市場の成長を促進する主要因となっています。慢性疾患に罹患しやすい老人人口の増加が、世界市場の需要をさらに後押ししています。
世界保健機関(WHO)によると、これらの心臓病が原因で毎年約1,790万人が死亡しており、これは世界の死亡者数の約31.0%にあたると推定されています。これらの死亡者のうち、約740万人が脳卒中によるもので、約670万人が脳卒中によるものです。2030年までには、CVDによる死亡者数は全世界で約2,360万人に達すると予測されています。
Lifespan Health System(lifespan.org)によると、米国では毎年約50万件の開心術が行われています。この手術件数は今後も増加すると予想されています。このような手術では麻酔が非常に必要とされるため、このような外科手術の数の増加がこの世界市場の成長を促進すると予想されています。
2023年4月、マニトバ州政府は3,000万米ドルを投じて、スタインバッハのベセスダ地域医療センターに3つの新しい手術室を開設すると発表しました。これら3つの手術室には、手術機器や麻酔装置の最新ブームシステムが導入されます。このような病院拡張プロジェクトは、世界市場の成長に有利な機会を提供すると予想されます。これらの機器はコストが高いため、市場の需要を抑制する可能性があります。しかし、いくつかの外科手術に対する有利な償還政策は、市場成長に有利な機会を提供すると予想されます。
麻酔装置は、患者への輸液、薬物、ガスの供給を追跡する多様な装置群です。この装置は、患者のバイタルサインの監視と測定を支援し、患者の健康を確保します。世界の老人人口の増加と手術件数の増加が、市場を牽引する主な要因です。麻酔モニターは、医師がこの機器を受け入れ、認知した結果、より広く使用されるようになった。さらに、安全で標準的な機器や医療施設に対する需要がかつてないほど高まっていることも、市場を後押ししています。先進的な麻酔器の発売は、この市場セグメントの成長をさらに後押ししています。
世界の麻酔器市場は、北米(米国とカナダ)、欧州(イタリア、スペイン、ドイツ、フランス、その他)、アジア太平洋地域(インド、中国、日本、韓国、その他)、世界のその他の地域(中東とアフリカ、ラテンアメリカ)など、地域別にさらに細分化されています。2023年の世界市場では、北米が大きなシェアを占めています。同地域の市場シェアは、手術件数の多さ、高度な医療インフラ、医療費の高さに起因しています。主要市場プレイヤーの存在が、地域市場シェアをさらに押し上げています。
アジア太平洋地域は世界市場でかなりの成長を示すと予想される
アジア太平洋地域は、世界市場においてかなりの成長を示すと予想されます。医療費の増加、事故事例の増加、有利な償還政策、新興経済国における医療ツーリズムの拡大が、この地域の市場成長を促進する主要因となっています。2023年8月、Medovate社はSAFIRA(SAFer Injection for Regional Anesthesia)Palm Operatorをシンガポール市場で発売し、シンガポール保健科学庁(HSA)から承認を取得しました。地域全体での製品上市の増加は、地域市場の成長にさらに貢献しています。
Global Anesthesia Devices Market Size, Share & Trends Analysis Report by Product Type (Anesthesia Machines and Disposables & Accessories), and by End-User (Hospitals, Clinics, and Ambulatory Surgical Centers (ASCs)) Forecast Period (2024-2031)
The global anesthesia devices market is anticipated to grow at a considerable CAGR of 7.5% during the forecast period. The ongoing advancements in anesthesia delivery and monitoring technology along with the significant rise in the number of surgical procedures requiring anesthesia is a key factor driving the growth of the global market. The growing geriatric population which is highly susceptible to chronic diseases is further aiding the demand for the global market.
According to World Health Organization (WHO), around 17.9 million fatalities occur each year due to these heart diseases, which is estimated to be around 31.0% of the global fatalities. Amongst these fatalities, around 7.4 million had and approx. 6.7 million fatalities occurred due to a stroke. By 2030, it has been projected that CVDs will be responsible for approx. around 23.6 million mortalities across the globe.
According to the Lifespan Health System (lifespan.org), about 500,000 open heart surgeries are performed each year in the US. The number of these surgeries is expected to grow in the future. Anesthesia is highly required during such surgeries therefore; the growing number of such surgical procedures is anticipated to drive the growth of this global market.
In April 2023, with an investment of $30 million Manitoba government announced to launch of three new operating rooms for the Bethesda Regional Health Centre in Steinbach. These three operating theatres will be with a modern boom system for surgical and anesthesia equipment. Such hospital expansion projects are anticipated to offer lucrative opportunities for global market growth. The high cost of these devices may restrain its market demand. However, favorable reimbursement policies for several surgical procedures are anticipated to offer lucrative opportunities for market growth.
The global anesthesia devices market is segmented based on product type, and end-user. Based on product type, the market is segmented into anesthesia machines and disposables & and accessories. Anesthesia machines are further sub-segmented into anesthesia delivery machines, anesthesia ventilators, and anesthesia monitors. The disposable & and accessories are further sub-segmented into Anesthesia Circuits (Breathing Circuits), anesthesia masks, Endotracheal Tubes (ETTs), and Laryngeal Mask Airways (LMAs). Based on end-users, the market is segmented into hospitals, clinics, and ambulatory surgical centers.
Anesthesia devices are a diverse group of devices that track the delivery of fluids, medications, and gases to a patient. The devices assist in the monitoring and measurement of patients' vital signs to ensure their well-being. The increase in the global geriatric population, as well as the rising rate of surgeries, is the primary driving factor of the market. Anesthesia monitors have become more widely used as a result of physician acceptance and awareness of the devices. Furthermore, the market is being propelled by the demand for safe and standard equipment and medical facilities, which is at an all-time high. The advanced anesthesia machine launches are further aiding the growth of this market segment.
The global anesthesia devices market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). North America held a major share of the global market in 2023. The regional market share is attributed to the large number of surgical procedures, advanced healthcare infrastructure, and high medical expenditure. The presence of key market players is further aiding the regional market share.
Asia-Pacific is anticipated to Exhibit Considerable Growth in the Global Market
Asia-Pacific is anticipated to exhibit considerable growth in the global market. The growing medical expenditure, rising accident cases, favorable reimbursement policies, and growing medical tourism in emerging economies a key factors driving the regional market growth. In August 2023, Medovate launched the SAFIRA (SAFer Injection for Regional Anesthesia) Palm Operator in the Singapore market with secured approval from the Singapore Health Sciences Authority (HSA). The increased product launches across the region are further contributing to the regional market growth.
The major companies serving the global anesthesia devices market include Medtronic PLC, Draegerwerk AG, Koninklijke Philips NV, Fisher & Paykel Healthcare, and B. Braun SE among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and advancement in their product offerings to stay competitive in the market. For instance, in August 2023, Mindray unveiled upgrades to its A7 and A5 anesthesia systems under the A Series Anesthesia. These enhancements incorporate innovative technologies that empower anesthesiologists to deliver precise anesthesia, leading to greater patient safety and efficiency throughout the perioperative period.